Pluri Inc. Logo

Pluri Inc.

Biotechnology firm with 3D cell-expansion tech for manufacturing cell-based products.

PLUR | TA

Overview

Corporate Details

ISIN(s):
US72942G2030
LEI:
Country:
Israel
Address:
Park Building No. 5, 3508409 Haifa

Description

Pluri Inc. is a biotechnology company specializing in proprietary 3D cell-expansion technology. The company develops and operates platforms for the scalable, consistent, and cost-effective manufacturing of cell-based products. Its technology is applied across multiple sectors, including regenerative medicine, cell therapy, food technology, and agriculture technology (AgTech). Pluri aims to create next-generation cell-based products to improve human wellbeing and establishes partnerships to leverage its platform. The company also provides Contract Development and Manufacturing Organization (CDMO) services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-10 00:23
Immediate Report
English 869.3 KB
2025-12-10 00:23
Immediate Report
English 36.5 KB
2025-12-09 16:31
Pluri Appoints Alejandro Weinstein as Chairman of the Board to Lead Strategic S…
English 130.5 KB
2025-12-09 16:31
Pluri Appoints Alejandro Weinstein as Chairman of the Board to Lead Strategic S…
English 36.4 KB
2025-12-09 00:29
Other Report or Announcement
English 283.7 KB
2025-12-09 00:29
Other Report or Announcement
English 36.5 KB
2025-12-09 00:26
Other Report or Announcement
English 163.6 KB
2025-12-09 00:26
Other Report or Announcement
English 36.5 KB
2025-12-09 00:25
Other Report or Announcement
English 165.1 KB
2025-12-09 00:25
Other Report or Announcement
English 36.4 KB
2025-12-09 00:23
Other Report or Announcement
English 163.4 KB
2025-12-09 00:23
Other Report or Announcement
English 36.4 KB
2025-12-09 00:22
Other Report or Announcement
English 163.7 KB
2025-12-09 00:22
Other Report or Announcement
English 36.4 KB
2025-12-09 00:21
Other Report or Announcement
English 163.3 KB

Automate Your Workflow. Get a real-time feed of all Pluri Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pluri Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pluri Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures biologic medicines, including biosimilars and novel drugs.
South Korea
007460
Develops drugs for intractable diseases by regulating oxidative stress and CAFs.
South Korea
293780
Aptamer Sciences Inc Logo
Clinical-stage company developing aptamer-based therapeutics for oncology.
South Korea
291650
Aptorum Group Ltd Logo
Clinical-stage biopharma developing therapeutics for oncology and infectious diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Pharmaceutical company developing oral film medicines for CNS and allergic reactions.
United States of America
AQST
Arbutus Biopharma Corp Logo
Clinical-stage biopharma company developing a functional cure for chronic Hepatitis B.
United States of America
ABUS
Arcellx, Inc. Logo
A clinical-stage biotech company developing immunotherapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharmaceutical and nutraceutical products from marine membrane lipids.
Norway
ABS
ArcticZymes Technologies Logo
Develops and manufactures novel recombinant enzymes from Arctic marine organisms.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
United States of America
ARCT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.